Animals models on Drug Induced Renal Injury

The kidneys are exceptionally susceptible to drug-induced injury due to their high blood flow and the concentration of drugs during filtration and excretion. This condition, known as drug-induced renal injury (DIRI), is a significant contributor to acute kidney injury and can lead to chronic kidney disease. A range of common therapeutic agents, including aminoglycosides, cisplatin, non-steroidal anti-inflammatory drugs (NSAIDs), and calcineurin inhibitors, are recognized for their nephrotoxic potential. The resulting damage can affect various renal structures, such as the tubules, interstitium, glomeruli, or vasculature, with severity ranging from subtle, subclinical changes to severe dysfunction. Preclinical research utilizes models like rodents, zebrafish, and rabbits to explore DIRI mechanisms and screen for protective compounds. Key pathogenic pathways involve oxidative stress, inflammation, apoptosis, and mitochondrial damage. Despite these efforts, translating findings to clinical practice is challenging due to interspecies differences and inconsistent experimental designs. A major hurdle in managing DIRI is the delayed detection with traditional biomarkers like serum creatinine and BUN, which only rise after significant injury has occurred. Consequently, more sensitive and early indicators are being investigated. These novel biomarkers, such as Kidney Injury Molecule-1 (KIM-1), Neutrophil Gelatinase-Associated Lipocalin (NGAL), and inflammatory cytokines like IL-18 and TNF-alpha, offer the potential for earlier diagnosis. To improve clinical translation, future research must focus on standardizing study protocols, validating these new biomarkers, and employing advanced models like kidney organoids and microfluidic chips, which better replicate human kidney physiology.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24413373
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Animals models on Drug Induced Renal Injury

Venu Talla, Kompelli Bhanudeepika, Bathula Jayasri
Zenodo (CERN European Organization for Nuclear Research)
Acute Kidney Injury Research
article

Animals models on Drug Induced Renal Injury

Venu Talla, Kompelli Bhanudeepika, Bathula Jayasri
article en

Abstract

The kidneys are exceptionally susceptible to drug-induced injury due to their high blood flow and the concentration of drugs during filtration and excretion. This condition, known as drug-induced renal injury (DIRI), is a significant contributor to acute kidney injury and can lead to chronic kidney disease. A range of common therapeutic agents, including aminoglycosides, cisplatin, non-steroidal anti-inflammatory drugs (NSAIDs), and calcineurin inhibitors, are recognized for their nephrotoxic potential. The resulting damage can affect various renal structures, such as the tubules, interstitium, glomeruli, or vasculature, with severity ranging from subtle, subclinical changes to severe dysfunction. Preclinical research utilizes models like rodents, zebrafish, and rabbits to explore DIRI mechanisms and screen for protective compounds. Key pathogenic pathways involve oxidative stress, inflammation, apoptosis, and mitochondrial damage. Despite these efforts, translating findings to clinical practice is challenging due to interspecies differences and inconsistent experimental designs. A major hurdle in managing DIRI is the delayed detection with traditional biomarkers like serum creatinine and BUN, which only rise after significant injury has occurred. Consequently, more sensitive and early indicators are being investigated. These novel biomarkers, such as Kidney Injury Molecule-1 (KIM-1), Neutrophil Gelatinase-Associated Lipocalin (NGAL), and inflammatory cytokines like IL-18 and TNF-alpha, offer the potential for earlier diagnosis. To improve clinical translation, future research must focus on standardizing study protocols, validating these new biomarkers, and employing advanced models like kidney organoids and microfluidic chips, which better replicate human kidney physiology.

Zenodo (CERN European Organization for Nuclear Research)
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon